Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma
• Around 10% of the oral cancer patients would present dysplastic margin after surgery. • T1/T2 disease or tumor thickness ≤ 10 mm was significantly associated with dysplastic margin. • Disease control of dysplastic margin were significantly better than positive margin. • The severity of dysplasia h...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Chen, Tseng-Cheng [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
6 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole - 2012transfer abstract, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:97 ; year:2019 ; pages:1-6 ; extent:6 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.oraloncology.2019.07.015 |
|---|
| Katalog-ID: |
ELV047954639 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV047954639 | ||
| 003 | DE-627 | ||
| 005 | 20230624142111.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191023s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.oraloncology.2019.07.015 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000751.pica |
| 035 | |a (DE-627)ELV047954639 | ||
| 035 | |a (ELSEVIER)S1368-8375(19)30252-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 650 |q VZ |
| 084 | |a 85.03 |2 bkl | ||
| 084 | |a 31.80 |2 bkl | ||
| 084 | |a 54.80 |2 bkl | ||
| 084 | |a 50.03 |2 bkl | ||
| 100 | 1 | |a Chen, Tseng-Cheng |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma |
| 264 | 1 | |c 2019 | |
| 300 | |a 6 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Around 10% of the oral cancer patients would present dysplastic margin after surgery. • T1/T2 disease or tumor thickness ≤ 10 mm was significantly associated with dysplastic margin. • Disease control of dysplastic margin were significantly better than positive margin. • The severity of dysplasia had no significant impact on survival and local control. • Adjuvant RT could not provide benefit to patients with dysplastic margin. | ||
| 650 | 7 | |a Dysplastic margin |2 Elsevier | |
| 650 | 7 | |a Squamous cell carcinoma |2 Elsevier | |
| 650 | 7 | |a Oral cancer |2 Elsevier | |
| 650 | 7 | |a Mild dysplasia |2 Elsevier | |
| 650 | 7 | |a Local control |2 Elsevier | |
| 650 | 7 | |a Disease-free survival |2 Elsevier | |
| 650 | 7 | |a Severe dysplasia |2 Elsevier | |
| 650 | 7 | |a Overall survival |2 Elsevier | |
| 650 | 7 | |a Field cancerization |2 Elsevier | |
| 650 | 7 | |a Moderate dysplasia |2 Elsevier | |
| 700 | 1 | |a Chang, Huei-Lun |4 oth | |
| 700 | 1 | |a Yang, Tsung-Lin |4 oth | |
| 700 | 1 | |a Lou, Pei-Jen |4 oth | |
| 700 | 1 | |a Chang, Yih-Leong |4 oth | |
| 700 | 1 | |a Ko, Jenq-Yuh |4 oth | |
| 700 | 1 | |a Wang, Cheng-Ping |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |t Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |d 2012transfer abstract |g Amsterdam [u.a.] |w (DE-627)ELV011194073 |
| 773 | 1 | 8 | |g volume:97 |g year:2019 |g pages:1-6 |g extent:6 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.oraloncology.2019.07.015 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OPC-MAT | ||
| 936 | b | k | |a 85.03 |j Methoden und Techniken der Betriebswirtschaft |q VZ |
| 936 | b | k | |a 31.80 |j Angewandte Mathematik |q VZ |
| 936 | b | k | |a 54.80 |j Angewandte Informatik |q VZ |
| 936 | b | k | |a 50.03 |j Methoden und Techniken der Ingenieurwissenschaften |q VZ |
| 951 | |a AR | ||
| 952 | |d 97 |j 2019 |h 1-6 |g 6 | ||
| author_variant |
t c c tcc |
|---|---|
| matchkey_str |
chentsengchengchanghueilunyangtsunglinlo:2019----:matfypatcugclagnfrainsihrlq |
| hierarchy_sort_str |
2019 |
| bklnumber |
85.03 31.80 54.80 50.03 |
| publishDate |
2019 |
| allfields |
10.1016/j.oraloncology.2019.07.015 doi GBV00000000000751.pica (DE-627)ELV047954639 (ELSEVIER)S1368-8375(19)30252-0 DE-627 ger DE-627 rakwb eng 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Chen, Tseng-Cheng verfasserin aut Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Around 10% of the oral cancer patients would present dysplastic margin after surgery. • T1/T2 disease or tumor thickness ≤ 10 mm was significantly associated with dysplastic margin. • Disease control of dysplastic margin were significantly better than positive margin. • The severity of dysplasia had no significant impact on survival and local control. • Adjuvant RT could not provide benefit to patients with dysplastic margin. Dysplastic margin Elsevier Squamous cell carcinoma Elsevier Oral cancer Elsevier Mild dysplasia Elsevier Local control Elsevier Disease-free survival Elsevier Severe dysplasia Elsevier Overall survival Elsevier Field cancerization Elsevier Moderate dysplasia Elsevier Chang, Huei-Lun oth Yang, Tsung-Lin oth Lou, Pei-Jen oth Chang, Yih-Leong oth Ko, Jenq-Yuh oth Wang, Cheng-Ping oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:97 year:2019 pages:1-6 extent:6 https://doi.org/10.1016/j.oraloncology.2019.07.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 97 2019 1-6 6 |
| spelling |
10.1016/j.oraloncology.2019.07.015 doi GBV00000000000751.pica (DE-627)ELV047954639 (ELSEVIER)S1368-8375(19)30252-0 DE-627 ger DE-627 rakwb eng 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Chen, Tseng-Cheng verfasserin aut Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Around 10% of the oral cancer patients would present dysplastic margin after surgery. • T1/T2 disease or tumor thickness ≤ 10 mm was significantly associated with dysplastic margin. • Disease control of dysplastic margin were significantly better than positive margin. • The severity of dysplasia had no significant impact on survival and local control. • Adjuvant RT could not provide benefit to patients with dysplastic margin. Dysplastic margin Elsevier Squamous cell carcinoma Elsevier Oral cancer Elsevier Mild dysplasia Elsevier Local control Elsevier Disease-free survival Elsevier Severe dysplasia Elsevier Overall survival Elsevier Field cancerization Elsevier Moderate dysplasia Elsevier Chang, Huei-Lun oth Yang, Tsung-Lin oth Lou, Pei-Jen oth Chang, Yih-Leong oth Ko, Jenq-Yuh oth Wang, Cheng-Ping oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:97 year:2019 pages:1-6 extent:6 https://doi.org/10.1016/j.oraloncology.2019.07.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 97 2019 1-6 6 |
| allfields_unstemmed |
10.1016/j.oraloncology.2019.07.015 doi GBV00000000000751.pica (DE-627)ELV047954639 (ELSEVIER)S1368-8375(19)30252-0 DE-627 ger DE-627 rakwb eng 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Chen, Tseng-Cheng verfasserin aut Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Around 10% of the oral cancer patients would present dysplastic margin after surgery. • T1/T2 disease or tumor thickness ≤ 10 mm was significantly associated with dysplastic margin. • Disease control of dysplastic margin were significantly better than positive margin. • The severity of dysplasia had no significant impact on survival and local control. • Adjuvant RT could not provide benefit to patients with dysplastic margin. Dysplastic margin Elsevier Squamous cell carcinoma Elsevier Oral cancer Elsevier Mild dysplasia Elsevier Local control Elsevier Disease-free survival Elsevier Severe dysplasia Elsevier Overall survival Elsevier Field cancerization Elsevier Moderate dysplasia Elsevier Chang, Huei-Lun oth Yang, Tsung-Lin oth Lou, Pei-Jen oth Chang, Yih-Leong oth Ko, Jenq-Yuh oth Wang, Cheng-Ping oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:97 year:2019 pages:1-6 extent:6 https://doi.org/10.1016/j.oraloncology.2019.07.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 97 2019 1-6 6 |
| allfieldsGer |
10.1016/j.oraloncology.2019.07.015 doi GBV00000000000751.pica (DE-627)ELV047954639 (ELSEVIER)S1368-8375(19)30252-0 DE-627 ger DE-627 rakwb eng 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Chen, Tseng-Cheng verfasserin aut Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Around 10% of the oral cancer patients would present dysplastic margin after surgery. • T1/T2 disease or tumor thickness ≤ 10 mm was significantly associated with dysplastic margin. • Disease control of dysplastic margin were significantly better than positive margin. • The severity of dysplasia had no significant impact on survival and local control. • Adjuvant RT could not provide benefit to patients with dysplastic margin. Dysplastic margin Elsevier Squamous cell carcinoma Elsevier Oral cancer Elsevier Mild dysplasia Elsevier Local control Elsevier Disease-free survival Elsevier Severe dysplasia Elsevier Overall survival Elsevier Field cancerization Elsevier Moderate dysplasia Elsevier Chang, Huei-Lun oth Yang, Tsung-Lin oth Lou, Pei-Jen oth Chang, Yih-Leong oth Ko, Jenq-Yuh oth Wang, Cheng-Ping oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:97 year:2019 pages:1-6 extent:6 https://doi.org/10.1016/j.oraloncology.2019.07.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 97 2019 1-6 6 |
| allfieldsSound |
10.1016/j.oraloncology.2019.07.015 doi GBV00000000000751.pica (DE-627)ELV047954639 (ELSEVIER)S1368-8375(19)30252-0 DE-627 ger DE-627 rakwb eng 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Chen, Tseng-Cheng verfasserin aut Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma 2019 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Around 10% of the oral cancer patients would present dysplastic margin after surgery. • T1/T2 disease or tumor thickness ≤ 10 mm was significantly associated with dysplastic margin. • Disease control of dysplastic margin were significantly better than positive margin. • The severity of dysplasia had no significant impact on survival and local control. • Adjuvant RT could not provide benefit to patients with dysplastic margin. Dysplastic margin Elsevier Squamous cell carcinoma Elsevier Oral cancer Elsevier Mild dysplasia Elsevier Local control Elsevier Disease-free survival Elsevier Severe dysplasia Elsevier Overall survival Elsevier Field cancerization Elsevier Moderate dysplasia Elsevier Chang, Huei-Lun oth Yang, Tsung-Lin oth Lou, Pei-Jen oth Chang, Yih-Leong oth Ko, Jenq-Yuh oth Wang, Cheng-Ping oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:97 year:2019 pages:1-6 extent:6 https://doi.org/10.1016/j.oraloncology.2019.07.015 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 97 2019 1-6 6 |
| language |
English |
| source |
Enthalten in Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole Amsterdam [u.a.] volume:97 year:2019 pages:1-6 extent:6 |
| sourceStr |
Enthalten in Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole Amsterdam [u.a.] volume:97 year:2019 pages:1-6 extent:6 |
| format_phy_str_mv |
Article |
| bklname |
Methoden und Techniken der Betriebswirtschaft Angewandte Mathematik Angewandte Informatik Methoden und Techniken der Ingenieurwissenschaften |
| institution |
findex.gbv.de |
| topic_facet |
Dysplastic margin Squamous cell carcinoma Oral cancer Mild dysplasia Local control Disease-free survival Severe dysplasia Overall survival Field cancerization Moderate dysplasia |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| authorswithroles_txt_mv |
Chen, Tseng-Cheng @@aut@@ Chang, Huei-Lun @@oth@@ Yang, Tsung-Lin @@oth@@ Lou, Pei-Jen @@oth@@ Chang, Yih-Leong @@oth@@ Ko, Jenq-Yuh @@oth@@ Wang, Cheng-Ping @@oth@@ |
| publishDateDaySort_date |
2019-01-01T00:00:00Z |
| hierarchy_top_id |
ELV011194073 |
| dewey-sort |
3610 |
| id |
ELV047954639 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV047954639</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624142111.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191023s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.oraloncology.2019.07.015</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000751.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV047954639</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1368-8375(19)30252-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">650</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">85.03</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">31.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">54.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">50.03</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Chen, Tseng-Cheng</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Around 10% of the oral cancer patients would present dysplastic margin after surgery. • T1/T2 disease or tumor thickness ≤ 10 mm was significantly associated with dysplastic margin. • Disease control of dysplastic margin were significantly better than positive margin. • The severity of dysplasia had no significant impact on survival and local control. • Adjuvant RT could not provide benefit to patients with dysplastic margin.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dysplastic margin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Squamous cell carcinoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oral cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Mild dysplasia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Local control</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Disease-free survival</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Severe dysplasia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Overall survival</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Field cancerization</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Moderate dysplasia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chang, Huei-Lun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Tsung-Lin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lou, Pei-Jen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chang, Yih-Leong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ko, Jenq-Yuh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Cheng-Ping</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole</subfield><subfield code="d">2012transfer abstract</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011194073</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:97</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:1-6</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.oraloncology.2019.07.015</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-MAT</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">85.03</subfield><subfield code="j">Methoden und Techniken der Betriebswirtschaft</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">31.80</subfield><subfield code="j">Angewandte Mathematik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">54.80</subfield><subfield code="j">Angewandte Informatik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">50.03</subfield><subfield code="j">Methoden und Techniken der Ingenieurwissenschaften</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">97</subfield><subfield code="j">2019</subfield><subfield code="h">1-6</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
| author |
Chen, Tseng-Cheng |
| spellingShingle |
Chen, Tseng-Cheng ddc 610 ddc 650 bkl 85.03 bkl 31.80 bkl 54.80 bkl 50.03 Elsevier Dysplastic margin Elsevier Squamous cell carcinoma Elsevier Oral cancer Elsevier Mild dysplasia Elsevier Local control Elsevier Disease-free survival Elsevier Severe dysplasia Elsevier Overall survival Elsevier Field cancerization Elsevier Moderate dysplasia Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma |
| authorStr |
Chen, Tseng-Cheng |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV011194073 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 650 - Management & auxiliary services |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma Dysplastic margin Elsevier Squamous cell carcinoma Elsevier Oral cancer Elsevier Mild dysplasia Elsevier Local control Elsevier Disease-free survival Elsevier Severe dysplasia Elsevier Overall survival Elsevier Field cancerization Elsevier Moderate dysplasia Elsevier |
| topic |
ddc 610 ddc 650 bkl 85.03 bkl 31.80 bkl 54.80 bkl 50.03 Elsevier Dysplastic margin Elsevier Squamous cell carcinoma Elsevier Oral cancer Elsevier Mild dysplasia Elsevier Local control Elsevier Disease-free survival Elsevier Severe dysplasia Elsevier Overall survival Elsevier Field cancerization Elsevier Moderate dysplasia |
| topic_unstemmed |
ddc 610 ddc 650 bkl 85.03 bkl 31.80 bkl 54.80 bkl 50.03 Elsevier Dysplastic margin Elsevier Squamous cell carcinoma Elsevier Oral cancer Elsevier Mild dysplasia Elsevier Local control Elsevier Disease-free survival Elsevier Severe dysplasia Elsevier Overall survival Elsevier Field cancerization Elsevier Moderate dysplasia |
| topic_browse |
ddc 610 ddc 650 bkl 85.03 bkl 31.80 bkl 54.80 bkl 50.03 Elsevier Dysplastic margin Elsevier Squamous cell carcinoma Elsevier Oral cancer Elsevier Mild dysplasia Elsevier Local control Elsevier Disease-free survival Elsevier Severe dysplasia Elsevier Overall survival Elsevier Field cancerization Elsevier Moderate dysplasia |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
h l c hlc t l y tly p j l pjl y l c ylc j y k jyk c p w cpw |
| hierarchy_parent_title |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| hierarchy_parent_id |
ELV011194073 |
| dewey-tens |
610 - Medicine & health 650 - Management & public relations |
| hierarchy_top_title |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV011194073 |
| title |
Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma |
| ctrlnum |
(DE-627)ELV047954639 (ELSEVIER)S1368-8375(19)30252-0 |
| title_full |
Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma |
| author_sort |
Chen, Tseng-Cheng |
| journal |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| journalStr |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
zzz |
| container_start_page |
1 |
| author_browse |
Chen, Tseng-Cheng |
| container_volume |
97 |
| physical |
6 |
| class |
610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Chen, Tseng-Cheng |
| doi_str_mv |
10.1016/j.oraloncology.2019.07.015 |
| dewey-full |
610 650 |
| title_sort |
impact of dysplastic surgical margins for patients with oral squamous cell carcinoma |
| title_auth |
Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma |
| abstract |
• Around 10% of the oral cancer patients would present dysplastic margin after surgery. • T1/T2 disease or tumor thickness ≤ 10 mm was significantly associated with dysplastic margin. • Disease control of dysplastic margin were significantly better than positive margin. • The severity of dysplasia had no significant impact on survival and local control. • Adjuvant RT could not provide benefit to patients with dysplastic margin. |
| abstractGer |
• Around 10% of the oral cancer patients would present dysplastic margin after surgery. • T1/T2 disease or tumor thickness ≤ 10 mm was significantly associated with dysplastic margin. • Disease control of dysplastic margin were significantly better than positive margin. • The severity of dysplasia had no significant impact on survival and local control. • Adjuvant RT could not provide benefit to patients with dysplastic margin. |
| abstract_unstemmed |
• Around 10% of the oral cancer patients would present dysplastic margin after surgery. • T1/T2 disease or tumor thickness ≤ 10 mm was significantly associated with dysplastic margin. • Disease control of dysplastic margin were significantly better than positive margin. • The severity of dysplasia had no significant impact on survival and local control. • Adjuvant RT could not provide benefit to patients with dysplastic margin. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT |
| title_short |
Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma |
| url |
https://doi.org/10.1016/j.oraloncology.2019.07.015 |
| remote_bool |
true |
| author2 |
Chang, Huei-Lun Yang, Tsung-Lin Lou, Pei-Jen Chang, Yih-Leong Ko, Jenq-Yuh Wang, Cheng-Ping |
| author2Str |
Chang, Huei-Lun Yang, Tsung-Lin Lou, Pei-Jen Chang, Yih-Leong Ko, Jenq-Yuh Wang, Cheng-Ping |
| ppnlink |
ELV011194073 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth |
| doi_str |
10.1016/j.oraloncology.2019.07.015 |
| up_date |
2024-07-06T17:34:08.906Z |
| _version_ |
1803851922310955008 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV047954639</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624142111.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191023s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.oraloncology.2019.07.015</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000751.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV047954639</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1368-8375(19)30252-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">650</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">85.03</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">31.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">54.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">50.03</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Chen, Tseng-Cheng</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Impact of dysplastic surgical margins for patients with oral squamous cell carcinoma</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Around 10% of the oral cancer patients would present dysplastic margin after surgery. • T1/T2 disease or tumor thickness ≤ 10 mm was significantly associated with dysplastic margin. • Disease control of dysplastic margin were significantly better than positive margin. • The severity of dysplasia had no significant impact on survival and local control. • Adjuvant RT could not provide benefit to patients with dysplastic margin.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dysplastic margin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Squamous cell carcinoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oral cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Mild dysplasia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Local control</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Disease-free survival</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Severe dysplasia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Overall survival</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Field cancerization</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Moderate dysplasia</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chang, Huei-Lun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Tsung-Lin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lou, Pei-Jen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chang, Yih-Leong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ko, Jenq-Yuh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Cheng-Ping</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole</subfield><subfield code="d">2012transfer abstract</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011194073</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:97</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:1-6</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.oraloncology.2019.07.015</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-MAT</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">85.03</subfield><subfield code="j">Methoden und Techniken der Betriebswirtschaft</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">31.80</subfield><subfield code="j">Angewandte Mathematik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">54.80</subfield><subfield code="j">Angewandte Informatik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">50.03</subfield><subfield code="j">Methoden und Techniken der Ingenieurwissenschaften</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">97</subfield><subfield code="j">2019</subfield><subfield code="h">1-6</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
| score |
7.400199 |